Earnings ·
Labcorp raises full-year adjusted EPS guidance to $18.30-$18.70 after Q3 revenue of $3.81B
LHLabcorp Holdings Inc.
Labcorp Holdings Inc. reported third-quarter 2026 revenue of $3.81 billion, a 6.9% increase from the prior year period, and diluted earnings per share of $3.22. The company raised its full-year adjusted EPS guidance to a range of $18.30 to $18.70, up 18 cents at the midpoint, citing strong performance in specialty testing and margin expansion. Labcorp also announced four M&A transactions expected to be accretive to earnings and received FDA approval for a companion diagnostic for advanced melanoma. The global leader of innovative and comprehensive laboratory services provides diagnostics and drug development support.